As shown in Fig 1, with the exception of the p-value for AA and EA combined (Panel A), AFP was unable to distinguish HCC from cirrhosis in AA (Panel B and B1) or EA (Panel C and C1), emphasizing the need for more potent HCC markers particularly for subjects with HCV+. Here, AFP is linked to hepatocellular carcinoma.